Skip to main content
. Author manuscript; available in PMC: 2007 Dec 20.
Published in final edited form as: J Neurosci. 2005 Jan 19;25(3):748–757. doi: 10.1523/JNEUROSCI.2399-04.2005

Figure 10.

Figure 10

The cell death induced by the expression of mutant PRPF31 proteins was significantly reduced by the treatment with BAF, a caspase inhibitor. Transfection and TUNEL staining were performed as described for Figure 9, except BAF or vehicle control was added to the cultured retinal cells. In the absence of BAF, cells expressing mutant PRPF31, either N371 or N256, showed a significantly increased percentage of TUNEL-positive cells compared with cells expressing GFP alone or wild-type (wt) PRPF31 (**p<0.01). Treatment with BAF blocked cell death and eliminated the differences between the mutant groups (*) and control groups.